SCYNEXIS (SCYX) Earnings Date, Estimates & Call Transcripts $1.01 -0.10 (-9.01%) (As of 05:27 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SCYNEXIS Latest Earnings SummaryActual EPS (Nov. 6) -$0.06 Beat By $0.14 Consensus EPS (Nov. 6) -$0.20 SCYNEXIS released Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.06, which topped the consensus estimate of -$0.20 by $0.14. Quarterly revenue was reported to be $0.66 million. With a trailing EPS of -$0.74, SCYNEXIS's earnings are expected to grow next year, from ($0.55) to $0.05 per share. Get SCYNEXIS Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SCYNEXIS and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSCYX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SCYX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. SCYNEXIS Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.18-$0.18-$0.18Q2 20241-$0.19-$0.19-$0.19Q3 20241-$0.20-$0.20-$0.20Q4 20241$0.01$0.01$0.01FY 20244-$0.56-$0.56-$0.56Q1 20251$0.00$0.00$0.00Q2 20251$0.01$0.01$0.01Q3 20251$0.02$0.02$0.02Q4 20251$0.05$0.05$0.05FY 20254$0.08$0.08$0.08 SCYNEXIS Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/6/2024--$0.20-$0.06+$0.14-$0.06-$0.66M8/8/2024--$0.19-$0.30 -$0.11-$0.30-$0.74M5/8/2024Q1 2024-$0.18-$0.15+$0.03-$0.31-$1.37M3/28/2024Q4 2023$0.31-$0.39 -$0.70-$0.39$26.14M$5.80M11/13/2023Q3 2023$0.29-$0.04 -$0.33-$0.04$25.00M$1.76M8/14/2023Q2 2023$1.03$2.46+$1.43$2.46$91.50M$131.45M Get the Latest News and Ratings for SCYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SCYNEXIS and its competitors with MarketBeat's FREE daily newsletter. 5/11/2023Q1 2023-$0.28-$0.25+$0.03$0.21$1.50M$1.13M3/31/2023Q4 2022-$0.50-$0.29+$0.21-$0.29$1.28M$1.52M SCYNEXIS Earnings - Frequently Asked Questions When did SCYNEXIS announce their last quarterly earnings? SCYNEXIS (NASDAQ:SCYX) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on SCYX's earnings history. Did SCYNEXIS beat their earnings estimates last quarter? In the previous quarter, SCYNEXIS (NASDAQ:SCYX) reported ($0.06) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.20) by $0.14. Learn more on analysts' earnings estimate vs. SCYX's actual earnings. How much revenue does SCYNEXIS generate each year? SCYNEXIS (NASDAQ:SCYX) has a recorded annual revenue of $8.57 million. How much profit does SCYNEXIS generate each year? SCYNEXIS (NASDAQ:SCYX) has a recorded net income of $67.04 million. SCYX has generated -$0.74 earnings per share over the last four quarters. What is SCYNEXIS's EPS forecast for next year? SCYNEXIS's earnings are expected to grow from ($0.55) per share to $0.05 per share in the next year. More Earnings Resources from MarketBeat Related Companies Nkarta Earnings Date Checkpoint Therapeutics Earnings Date scPharmaceuticals Earnings Date Zura Bio Earnings Date Cidara Therapeutics Earnings Date Ventyx Biosciences Earnings Date TScan Therapeutics Earnings Date Seres Therapeutics Earnings Date FitLife Brands Earnings Date Adaptimmune Therapeutics Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now This page (NASDAQ:SCYX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SCYNEXIS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SCYNEXIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.